布地奈德对变应性鼻炎患者外周血树突状细胞免疫功能的影响

申震, 李白芽, 戴浩, 等. 布地奈德对变应性鼻炎患者外周血树突状细胞免疫功能的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(18): 1391-1395. doi: 10.13201/j.issn.1001-1781.2018.18.007
引用本文: 申震, 李白芽, 戴浩, 等. 布地奈德对变应性鼻炎患者外周血树突状细胞免疫功能的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(18): 1391-1395. doi: 10.13201/j.issn.1001-1781.2018.18.007
SHEN Zhen, LI Baiya, DAI Hao, et al. Effects of budesonide aerosol inhalation on the immunological functions of peripheral dendritic cells in patients with allergic rhinitis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(18): 1391-1395. doi: 10.13201/j.issn.1001-1781.2018.18.007
Citation: SHEN Zhen, LI Baiya, DAI Hao, et al. Effects of budesonide aerosol inhalation on the immunological functions of peripheral dendritic cells in patients with allergic rhinitis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(18): 1391-1395. doi: 10.13201/j.issn.1001-1781.2018.18.007

布地奈德对变应性鼻炎患者外周血树突状细胞免疫功能的影响

详细信息
    通讯作者: 邵渊,E-mail:shaxiaoying1976@163.com
  • 中图分类号: R765.21

Effects of budesonide aerosol inhalation on the immunological functions of peripheral dendritic cells in patients with allergic rhinitis

More Information
  • 目的:探讨布地奈德鼻喷雾剂治疗变应性鼻炎(AR)过程中患者外周血树突状细胞(DC)免疫功能的变化。方法:选取中重度持续性AR患者25例,给予布地奈德鼻喷雾剂治疗8周,评估患者治疗前、治疗4周和8周时患者AR相关症状和指标、外周血DC数量、比例以及活化程度的变化。结果:AR患者治疗4周和8周后症状评分、嗜酸粒细胞比例以及血清AR特异性抗体sIgE和T-IgE均下降,差异有统计学意义,治疗结束时总有效率达到88%。患者DC细胞数目和DC/PBMC较治疗前降低,差异有统计学意义(P<0.05)。与治疗前相比,AR患者治疗4周和8周后,活化DC细胞表面标志分子CD86和CD80均不同程度降低,而糖皮质激素诱导的亮氨酸拉链蛋白逐渐升高,均差异有统计学意义(P<0.05)。与治疗前相比,DC细胞分泌的IL-10的浓度随着治疗时间延长而降低,同时DC刺激T细胞分泌的IFN-γ水平在治疗后显著升高,均差异有统计学意义(P<0.05)。结论:布地奈德有助于抑制AR患者外周血DC的活化和成熟,这可能与其纠正DC参与的Th2反应从而减轻患者症状有关。
  • 加载中
  • [1]

    WEI P, HU G H, KANG H Y, et al.An aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress the Th17response in allergic rhinitis patients[J].Lab Invest, 2014, 94:528-535.

    [2]

    SHAMJI M H, DURHAM S R.Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers[J].J Allergy Clin Immunol, 2017, 140:1485-1498.

    [3]

    WALLACE D V, DYKEWICZ M S, OPPENHEIMER J, et al.Pharmacologic treatment of seasonal allergic rhinitis:synopsis of guidance from the 2017joint task force on practice parameters[J].Ann Intern Med, 2017, 167:876-881.

    [4]

    SAMOLINSKI B, NOWICKA A, WOJAS O, et al.Intranasal glucocorticosteroids-not only in allergic rhinitis In the 40th anniversary of intranasal glucocorticosteroids' introduction[J].Otolaryngol Pol, 2014, 68:51-64.

    [5]

    姜军合, 范学政.布地奈德对变应性鼻炎患者Th1/Th2细胞因子的影响[J].实用医学杂志, 2007, 23(21):3357-3358.

    [6]

    SHAMJI M H, BELLIDO V, SCADDING G W, et al.Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals[J].Allergy, 2015, 70:171-179.

    [7]

    范小红, 董强刚, 包国良, 等.非小细胞肺癌外周血树突状细胞含量与血管内皮生长因子浓度的关系[J].中国肺癌杂志, 2002, 5(4):268-271.

    [8]

    CHANG W A, HUNG J Y, JIAN S F, et al.Laricitrin ameliorates lung cancer-mediated dendritic cell suppression by inhibiting signal transducer and activator of transcription 3[J].Oncotarget, 2016, 7:85220-85234.

    [9]

    唐力行, 高娟, 张亚梅.布地奈德盐水鼻腔冲洗治疗儿童鼻-鼻窦炎疗效分析[J].临床耳鼻咽喉头颈外科杂志, 2016, 30(12):952-954.

    [10]

    ROSENBERG H F, DYER K D, FOSTER P S.Eosinophils:changing perspectives in health and disease[J].Nat Rev Immunol, 2013, 13:9-22.

    [11]

    李雪盛, 钱进, 李厚恩.变应性鼻炎外周血嗜酸性粒细胞含量及其辅助诊断价值[J].中国实验诊断学, 2016, 20(12):2070-2071.

    [12]

    LOTFI R, LOTZE M T.Eosinophils induce DC maturation, regulating immunity[J].J Leukoc Biol, 2008, 83:456-460.

    [13]

    YANG D, CHEN Q, SU S B, et al.Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88signal pathway in dendritic cells and enhances Th2immune responses[J].J Exp Med, 2008, 205:79-90.

    [14]

    LIN J Y, TA Y C, LIU I L, et al.Suppressive effects of primed eosinophils on single epicutaneous sensitization through regulation of dermal dendritic cells[J].Exp Dermatol, 2016, 25:548-552.

    [15]

    孙程成, 蒋子栋, 孙劲旅.树突状细胞与变应性鼻炎[J].国际耳鼻咽喉头颈外科杂志, 2013, 37(2):76-78.

    [16]

    CAO P P, SHI L L, XU K, et al.Dendritic cells in inflammatory sinonasal diseases[J].Clin Exp Allergy, 2016, 46:894-906.

    [17]

    EGUÍLUZ-GRACIA I, BOSCO A, DOLLNER R, et al.Rapid recruitment of CD14(+) monocytes in experimentally induced allergic rhinitis in human subjects[J].J Allergy Clin Immunol, 2016, 137:1872-1881.

    [18]

    CHAMBERS E S, NANZER A M, PFEFFER P E, et al.Dendritic cell phenotype in severe asthma reflects clinical responsiveness to glucocorticoids[J].Clin Exp Allergy, 2018, 48:13-22.

    [19]

    LUZ-CRAWFORD P, ESPINOSA-CARRASCO G, IPSEIZ N, et al.Gilz-Activin A as a novel signaling axis orchestrating mesenchymal stem cell and Th17cell interplay[J].Theranostics, 2018, 8:846-859.

    [20]

    CALMETTE J, BERTRAND M, VETILLARD M, et al.Glucocorticoid-induced leucine zipper protein controls macropinocytosis in dendritic cells[J].J Immunol, 2016, 197:4247-4256.

  • 加载中
计量
  • 文章访问数:  88
  • PDF下载数:  72
  • 施引文献:  0
出版历程
收稿日期:  2018-05-02

目录